The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes.

GUIDELINE TITLE 3 / hematopoietic stem cell transplantation
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes.

BIBLIOGRAPHIC SOURCE(S)
American Society for Blood and Marrow Transplantation. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes. Biol Blood Marrow Transplant 2009 Feb;15(2):135-6. [1 reference] PubMed


Oliansky DM, Antin JH, Bennett JM, Deeg HJ, Engelhardt C, Heptinstall KV, de Lima M, Gore SD, Potts RG, Silverman LR, Jones RB, McCarthy PL Jr, Hahn T. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review. Biol Blood Marrow Transplant 2009 Feb;15(2):137-72. [103 references] PubMed

GUIDELINE STATUS
This is the current release of the guideline.


abrir aquí para acceder al documento NGC AHRQ completo:
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes.